S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
S&P 500   4,320.06 (-0.23%)
DOW   33,963.84 (-0.31%)
QQQ   357.91 (+0.01%)
AAPL   174.79 (+0.49%)
MSFT   317.01 (-0.79%)
META   299.08 (+1.13%)
GOOGL   130.25 (-0.15%)
AMZN   129.12 (-0.16%)
TSLA   244.88 (-4.23%)
NVDA   416.10 (+1.45%)
NIO   8.54 (+1.07%)
BABA   88.30 (+4.98%)
AMD   96.20 (+0.09%)
T   15.13 (-1.18%)
F   12.43 (+1.89%)
MU   68.88 (+1.44%)
CGC   0.84 (+9.09%)
GE   111.25 (-1.54%)
DIS   81.25 (-1.79%)
AMC   7.63 (-0.91%)
PFE   32.69 (-0.49%)
PYPL   57.88 (-1.26%)
NFLX   379.81 (-1.13%)
NASDAQ:BNFT

Benefitfocus (BNFT) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$10.50
$10.50
50-Day Range
$10.45
$10.50
52-Week Range
$5.68
$13.06
Volume
N/A
Average Volume
253,843 shs
Market Capitalization
$362.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.50

BNFT stock logo

About Benefitfocus (NASDAQ:BNFT) Stock

Benefitfocus, Inc. provides cloud-based benefits management technology solutions for employers and health plans in the United States. Its products for employers comprise Benefitplace, a cloud-based benefits management portal that streamlines online enrollment, employee communication, and benefit administration; Health Insights, a data analytics solution; ACA Management and Reporting, a solution for employers to manage ACA compliance; Billing & Payments, an application that synchronizes enrollment and billing information to streamline the monthly billing process, automate adjustments, and enhance accuracy of payments; and COBRA Administration, a solution that simplifies management of Consolidated Omnibus Budget Reconciliation Act, benefits. The company's products for health plans include Enrollment that provides platform for carriers to automate enrollment across all segments of their commercial group business; Billing & Payments, an electronic invoice presentment and payment solution; Exchange, a solution that bridges the integration gap between health plan and employer systems; and Quoting that gives health plans and brokers tools to organize and proactively manage accounts, track leads, generate quotes, and create proposals for multiple products. Its products for brokers consist of Health Insights that support strategic decisions for their clients with on-demand health plan analytics; Benefit Catalog, which allows brokers to offer products to their clients; and benefit catalog consultative support for brokers through benefit advisors. The company also provides implementation services to its customers in order to help ensure seamless deployment and effective utilization of its solutions; and employers with expanded support services. The company was incorporated in 2000 and is headquartered in Charleston, South Carolina.


BNFT Stock News Headlines

Benefitfocus (NASDAQ: BNFT)
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Why Is Benefitfocus (BNFT) Stock Up 48% Today?
Benefitfocus Named a 2022 BenefitsPRO Luminaries Honoree
See More Headlines
Receive BNFT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Benefitfocus and its competitors with MarketBeat's FREE daily newsletter.

BNFT Company Calendar

Last Earnings
11/02/2021
Today
9/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:BNFT
Employees
1,100
Year Founded
2000

Price Target and Rating

Average Stock Price Forecast
$10.50
High Stock Price Forecast
$10.50
Low Stock Price Forecast
$10.50
Forecasted Upside/Downside
0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-32,170,000.00
Pretax Margin
-8.60%

Debt

Sales & Book Value

Annual Sales
$263.10 million
Cash Flow
$0.47 per share
Book Value
($2.28) per share

Miscellaneous

Free Float
29,355,000
Market Cap
$362.04 million
Optionable
Optionable
Beta
1.70

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Matthew C. Levin (Age 50)
    Pres, CEO & Director
    Comp: $858.56k
  • Ms. Alpana WegnerMs. Alpana Wegner (Age 50)
    CFO & Treasurer
    Comp: $517.74k
  • Mr. Ed Rumzis
    Chief Technology Officer
  • Mr. Michael Bauer
    Investor Relations
  • Joel Collins
    Gen. Counsel & Chief Legal Officer
  • Ms. Lou Anne Gilmore (Age 66)
    VP of Corp. Devel.
  • Mr. Peter Anthony Allen (Age 62)
    Sr. VP of Sales & Marketing
  • Ms. Ana Perez
    Chief Marketing Officer
  • Ms. Robin Kirby
    Chief HR Officer
  • Mr. Steve Malme
    Sr. VP of Platform Strategy & Experience













BNFT Stock - Frequently Asked Questions

Should I buy or sell Benefitfocus stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Benefitfocus in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BNFT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BNFT, but not buy additional shares or sell existing shares.
View BNFT analyst ratings
or view top-rated stocks.

What is Benefitfocus' stock price forecast for 2023?

1 analysts have issued 12 month price targets for Benefitfocus' shares. Their BNFT share price forecasts range from $10.50 to $10.50. On average, they expect the company's share price to reach $10.50 in the next year.
View analysts price targets for BNFT
or view top-rated stocks among Wall Street analysts.

How were Benefitfocus' earnings last quarter?

Benefitfocus, Inc. (NASDAQ:BNFT) announced its quarterly earnings results on Tuesday, November, 2nd. The software maker reported ($0.19) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.23) by $0.04. The software maker earned $62.03 million during the quarter, compared to the consensus estimate of $59 million. During the same quarter in the prior year, the business earned ($0.20) earnings per share.

What is Matt Levin's approval rating as Benefitfocus' CEO?

34 employees have rated Benefitfocus Chief Executive Officer Matt Levin on Glassdoor.com. Matt Levin has an approval rating of 60% among the company's employees. This puts Matt Levin in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 53.0% of employees surveyed would recommend working at Benefitfocus to a friend.

What other stocks do shareholders of Benefitfocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Benefitfocus investors own include Hawkins (HWKN), CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Designer Brands (DBI), STMicroelectronics (STM), Athabasca Oil (ATH) and

What is Benefitfocus' stock symbol?

Benefitfocus trades on the NASDAQ under the ticker symbol "BNFT."

What is Benefitfocus' stock price today?

One share of BNFT stock can currently be purchased for approximately $10.50.

How much money does Benefitfocus make?

Benefitfocus (NASDAQ:BNFT) has a market capitalization of $362.04 million and generates $263.10 million in revenue each year. The software maker earns $-32,170,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis.

How many employees does Benefitfocus have?

The company employs 1,100 workers across the globe.

Does Benefitfocus have any subsidiaries?
The following companies are subsidiares of Benefitfocus: BeliefNetworks Inc, BenefitStore Inc., Benefitfocus.com Inc., and Tango Health.
Read More
How can I contact Benefitfocus?

Benefitfocus' mailing address is 100 BENEFITFOCUS WAY, CHARLESTON SC, 29492. The official website for the company is www.benefitfocus.com. The software maker can be reached via phone at (843) 849-7476, via email at michael.bauer@benefitfocus.com, or via fax at 843-849-9485.

This page (NASDAQ:BNFT) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -